| [1] | Liossis SN, Ding XZ, Dennis GJ, Tsokos GC (1998) Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest 101: 1448-1457. doi:10.1172/JCI1457. PubMed: 9525988.
|
| [2] | Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365: 2110-2121. doi:10.1056/NEJMra1100359. PubMed: 22129255.
|
| [3] | Krishnan S, Juang YT, Chowdhury B, Magilavy A, Fisher CU et al. (2008) Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells. J Immunol 181: 8145-8152. PubMed: 19018007.
|
| [4] | Kyttaris VC (2010) Systemic lupus erythematosus: from genes to organ damage. Methods Mol Biol 662: 265-283. doi:10.1007/978-1-60761-800-3_13. PubMed: 20824476.
|
| [5] | Crispín JC, Kyttaris VC, Juang YT, Tsokos GC (2008) How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype. Trends Immunol 29: 110-115. doi:10.1016/j.it.2007.12.003. PubMed: 18249583.
|
| [6] | Grammatikos AP, Tsokos GC (2012) Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus. Trends Mol Med 18: 101-108. doi:10.1016/j.molmed.2011.10.005. PubMed: 22177735.
|
| [7] | Oliver JM, Burg DL, Wilson BS, McLaughlin JL, Geahlen RL (1994) Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J Biol Chem 269: 29697-29703. PubMed: 7961959.
|
| [8] | Nambiar MP, Fisher CU, Kumar A, Tsokos CG, Warke VG et al. (2003) Forced expression of the Fc receptor gamma-chain renders human T cells hyperresponsive to TCR/CD3 stimulation. J Immunol 170: 2871-2876. PubMed: 12626537.
|
| [9] | Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725. doi:10.1002/art.1780400929. PubMed: 9324032.
|
| [10] | Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35: 630-640. doi:10.1002/art.1780350606.
|
| [11] | Juang YT, Peoples C, Kafri R, Kyttaris VC, Sunahori K et al. (2011) A systemic lupus erythematosus gene expression array in disease diagnosis and classification: a preliminary report. Lupus 20: 243-249. doi:10.1177/0961203310383072. PubMed: 21138984.
|
| [12] | Crispín JC, Keenan BT, Finnell MD, Bermas BL, Schur P et al. (2010) Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity. Arthritis Rheum 62: 1431-1437. doi:10.1002/art.27385. PubMed: 20213807.
|
| [13] | Kyttaris VC, Tsokos GC (2011) Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus. Curr Opin Rheumatol 23: 449-453. doi:10.1097/BOR.0b013e328349a242. PubMed: 21720246.
|
| [14] | Grammatikos AP, Tsokos CG (2011) T cell abnormalities in patients with SLE (systemic lupus erythematosus). World Hellenic Biomedical. News 2: 7-11.
|
| [15] | Ghosh D, Tsokos GC, Kyttaris VC (2012) c-Jun and Ets2 proteins regulate expression of spleen tyrosine kinase in T cells. J Biol Chem 287: 11833-11841. doi:10.1074/jbc.M111.333997. PubMed: 22354960.
|
| [16] | Deng GM, Liu L, Bahjat FR, Pine PR, Tsokos GC (2010) Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice. Arthritis Rheum 62: 2086-2092. PubMed: 20222110.
|
| [17] | Sarra M, Monteleone G (2010) Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus. J Biomed Biotechnol, 2010: 294582. PubMed: 20652041.
|
| [18] | Li Y, Harada T, Juang YT, Kyttaris VC, Wang Y et al. (2007) Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus. J Immunol 178: 1938-1947. PubMed: 17237445.
|
| [19] | Cohen RA, Bayliss G, Crispin JC, Kane-Wanger GF, Van Beek CA et al. (2008) T cells and in situ cryoglobulin deposition in the pathogenesis of lupus nephritis. Clin Immunol 128: 1-7. doi:10.1016/j.clim.2008.04.004. PubMed: 18565470.
|
| [20] | Katsiari CG, Kyttaris VC, Juang YT, Tsokos GC (2005) Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J Clin Invest 115: 3193-3204. doi:10.1172/JCI24895. PubMed: 16224536.
|
| [21] | Crispín JC, Tsokos GC (2009) Transcriptional regulation of IL-2 in health and autoimmunity. Autoimmun Rev 8: 190-195. doi:10.1016/j.autrev.2008.07.042. PubMed: 18723131.
|
| [22] | Juang YT, Wang Y, Jiang G, Peng HB, Ergin S et al. (2008) PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells. J Immunol 181: 3658-3664. PubMed: 18714041.
|
| [23] | Crispín JC, Apostolidis SA, Rosetti F, Keszei M, Wang N et al. (2012) Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism. J Immunol 188: 3567-3571. doi:10.4049/jimmunol.1200143. PubMed: 22422882.
|
| [24] | Tang J, Gu Y, Zhang M, Ye S, Chen X et al. (2008) Increased expression of the type I interferon-inducible gene, lymphocyte antigen 6 complex locus E, in peripheral blood cells is predictive of lupus activity in a large cohort of Chinese lupus patients. Lupus 17: 805-813. doi:10.1177/0961203308089694. PubMed: 18755862.
|
| [25] | Pascual V, Farkas L, Banchereau J (2006) Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol 18: 676-682. doi:10.1016/j.coi.2006.09.014. PubMed: 17011763.
|
| [26] | Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL et al. (2005) Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 52: 201-211. doi:10.1002/art.20745. PubMed: 15641052.
|
| [27] | Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A (1996) Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 5: 591-604. doi:10.1016/S1074-7613(00)80273-3. PubMed: 8986718.
|
| [28] | Xu S, Huo J, Lee KG, Kurosaki T, Lam KP (2009) Phospholipase Cgamma2 is critical for Dectin-1-mediated Ca2+ flux and cytokine production in dendritic cells. J Biol Chem 284: 7038-7046. PubMed: 19136564.
|
| [29] | Dennehy KM, Willment JA, Williams DL, Brown GD (2009) Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur J Immunol 39: 1379-1386. doi:10.1002/eji.200838543. PubMed: 19291703.
|
| [30] | Chen G, Hardy K, Bunting K, Daley S, Ma L et al. (2010) Regulation of the IL-21 gene by the NF-kappaB transcription factor c-Rel. J Immunol 185: 2350-2359. doi:10.4049/jimmunol.1000317. PubMed: 20639489.
|
| [31] | Gee K, Lim W, Ma W, Nandan D, Diaz-Mitoma F et al. (2002) Differential regulation of CD44 expression by lipopolysaccharide (LPS) and TNF-alpha in human monocytic cells: distinct involvement of c-Jun N-terminal kinase in LPS-induced CD44 expression. J Immunol 169: 5660-5672. PubMed: 12421945.
|
